June 25, 2018
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Healthcare & Insurance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Intiva BioPharma Inc. |
| Registration Statement on Form S-1 | |
| File No. 333-225477 |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:00 PM (Eastern time) on Wednesday, June 27, 2018, or as soon thereafter as is practicable.
| Very truly yours, | ||
| INTIVA BIOPHARMA INC. | ||
| By: | /s/ Alain Bankier | |
| Alain Bankier | ||
| Chief Executive Officer | ||